Scripts for manuscript "Low amplitude copy number gains shape cancer through known and novel oncogenes with associated therapeutic vulnerabilities"
用于癌症拷贝数增益分析论文的R脚本和中间文件,不含原始数据。

基本信息
资源简介
Scripts for manuscript "Low amplitude copy number gains shape cancer through known and novel oncogenes with associated therapeutic vulnerabilities"
【一句话概览】
本数据集是 figshare 公开的文本数据集,收录 27 个文件、合计 172.40 MB,主题涵盖 Cancer Molecular aspects、chromosomal copy number alterations、biomarkers,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。
【数据集背景】
源站首次发布:2025-07-10。
【数据内容】
源站原始描述:Abstract: Large chromosomal copy number gains are ubiquitous throughout cancer types. However, which genes drive their selective advantage is not well established, and therefore they are hardly utilized in clinical practice. Our analysis of copy number patterns in pan-cancer datasets suggests that the selective advantage of copy number gains is largely driven by known oncogenes. Analysis of CRISPR screening data identifies a list of 101 genes that are likely to mediate the effect of these gains,…
文件 CCLE_prep.R 为文本内容,开头为:segments=readRDS(''./Files/220124_allSegmentsDEPMAP.rds'') sampleInfo=read.delim(''./Files/DEPMAP_sample_info.csv'',sep='','') achilles=fread(''./Files/CRISPRGeneEf…
文件 Figure 1_clean.R 为文本内容,开头为:Figure 1 TCGA segments=readRDS(''./Files/240410segments.rds'') sampleInfo=read.delim(''./Files/230309_combined_study_clinical_data.tsv'') colnames(…
文件 Figure 2_clean.R 为文本内容,开头为:load data and establish sample specific amplification threshold and arm level gain status source(''CCLE_prep.R'') Figure 2A Determing CN sta…
【数据结构与技术规格】
文件数 27 个,合计 172.40 MB。CCLE_prep.R:text/plain,6.13 KB。Figure 1_clean.R:text/plain,10.02 KB。Figure 2_clean.R:text/plain,9.47 KB。数据集 DOI:10.6084/m9.figshare.28956854.v1。
【主题与分类】
源站学科分类:Genomics。主题标签:Cancer Molecular aspects、chromosomal copy number alterations、biomarkers。
【适用方向】
文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面:https://figshare.com/articles/dataset/Scripts_for_manuscript_Low_amplitude_copy_number_gains_shape_cancer_through_known_and_novel_oncogenes_with_associated_therapeutic_vulnerabilities_/28956854
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Eleveld, Thomas (2025). Scripts for manuscript "Low amplitude copy number gains shape cancer through known and novel oncogenes with associated therapeutic vulnerabilities". figshare. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Scripts for manuscript “Low amplitude copy number gains shape cancer through known and novel oncogenes with associated therapeutic vulnerabilities”
- DOI:10.6084/m9.figshare.28956854.v1
- 发布日期:2025-07-10
- 文件数:27 个
- 文件总体积:172.40 MB
- 源站页面:https://figshare.com/articles/dataset/Scripts_for_manuscript_Low_amplitude_copy_number_gains_shape_cancer_through_known_and_novel_oncogenes_with_associated_therapeutic_vulnerabilities_/28956854
命令行下载
curl -L -o "CCLE_prep.R" "https://ndownloader.figshare.com/files/56095466"
curl -L -o "Figure 1_clean.R" "https://ndownloader.figshare.com/files/56095469"
curl -L -o "Figure 2_clean.R" "https://ndownloader.figshare.com/files/56095472"
curl -L -o "Figure 3_clean.R" "https://ndownloader.figshare.com/files/56095475"
curl -L -o "Figure 4_clean.R" "https://ndownloader.figshare.com/files/56095478"
curl -L -o "Figure 5_clean.R" "https://ndownloader.figshare.com/files/56095481"
curl -L -o "Figure_6_clean.R" "https://ndownloader.figshare.com/files/56095484"
curl -L -o "Functions and packages.R" "https://ndownloader.figshare.com/files/56095487"
文件清单
CCLE_prep.R(6.13 KB)Figure 1_clean.R(10.02 KB)Figure 2_clean.R(9.47 KB)Figure 3_clean.R(13.41 KB)Figure 4_clean.R(6.99 KB)Figure 5_clean.R(6.09 KB)Figure_6_clean.R(12.17 KB)Functions and packages.R(20.58 KB)Supplementary Figure 1.R(1.64 KB)Supplementary Figure 2.R(3.16 KB)Supplementary Figure 3.R(3.88 KB)Supplementary Figure 4.R(6.35 KB)Supplementary Figure 5.R(782 B)Supplementary Figure 6.R(3.32 KB)Supplementary Figure 7.R(1.90 KB)Supplementary Figure 8.R(1.83 KB)Supplementary Figure 9.R(1.11 KB)Supplementary Figure 10.R(1.70 KB)Supplementary Figure 11.R(2.13 KB)intermediate_files.zip(172.26 MB)
文件总体积 172.40 MB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Abstract:
Large chromosomal copy number gains are ubiquitous throughout cancer types. However, which genes drive their selective advantage is not well established, and therefore they are hardly utilized in clinical practice. Our analysis of copy number patterns in pan-cancer datasets suggests that the selective advantage of copy number gains is largely driven by known oncogenes. Analysis of CRISPR screening data identifies a list of 101 genes that are likely to mediate the effect of these gains, which is highly enriched in annotated oncogenes but also contains genes that have not been implicated in cancer so far. Moreover, we show that specific gains are associated with drug sensitivity or resistance, with a strong enrichment of gains of oncogenes with increased sensitivity to inhibitors targeting these specific genes. Finally, we provide examples where gains can function as relevant clinical biomarkers for diagnosis and treatment. Thus, large copy number gains exert their selective advantage through known and novel oncogenes and their systematic analysis could advance precision oncology.
Description
This share contains the R-scripts used to generate the figures and supplementary figures from the mentioned manuscript. All the neccesary packages and custom functions can be found in the Functions and Packages script. Intermediate files and other necessary files can be found in the intermediate_files ZIP file. Source files (segmented CN data, drug screening data, CRISPR screening data etc.) is not included but can be downloaded from the respective sources (Supplementary Table 1).
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.28956854.v1(source: https://figshare.com/articles/dataset/Scripts_for_manuscript_Low_amplitude_copy_number_gains_shape_cancer_through_known_and_novel_oncogenes_with_associated_therapeutic_vulnerabilities_/28956854)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




